Condition
mTBI
Total Trials
4
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04437498Not ApplicableRecruiting
Vagal Nerve Stimulation in mTBI
NCT03836976Not ApplicableCompletedPrimary
Detection and Amelioration of Gamma Oscillation Abnormalities in Blast-Related Brain Injury
NCT04195685Not ApplicableCompleted
Neurofeedback Impact on Veterans With mTBI
NCT01661075CompletedPrimary
Quantification of Balance in Acutely Concussed Athletes
Showing all 4 trials